What does HBM Healthcare invest in?
HBM Healthcare invests most often at Series B and Series C (71% of the rounds on record).
Last cheque observed May 2026; 8 cheques on record.
Deploying nowGrowth equity
Follow HBM Healthcare and see its new cheques in your feed.Start following
1 cheques in the last 12 months
Mostly Series B and Series C: 71% of its rounds
Every round we can evidence, newest first8 appearances
1 round
2 rounds
2 rounds
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as HBM Healthcare. A count of rooms they were both in, not a relationship either has claimed.
The latest companies HBM Healthcare put money into.
HBM Healthcare invests most often at Series B and Series C (71% of the rounds on record).
8 investments on record, 1 of them in the last 12 months. The most recent was in May 2026.
Its most recent investments on record: CellCentric (Growth, May 2026), Arrakis Therapeutics (Series B, Apr 2019) and SpringWorks Therapeutics (Series B, Apr 2019).
The median round it joins is $83M.
Rarely, if at all: none of its 8 investments on record names it as the lead.
Most of the companies it backs are in the United States (86%) and Denmark (14%).
Yes: it is actively investing, with 1 investments in the last 12 months.
Most often Pfizer (3 rounds together), Fidelity (2 rounds together) and OrbiMed (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it